ABIN-2 plays a crucial role in protecting endothelial cells from apoptosis and mediates the survival effects of the Tie2-activating ligand angiopoietin-1.
Answers are grounded in this paper and cite their sources.
ABIN-2 modulation remains investigational for endothelial protection; leaves open therapeutic relevance in human vascular disease.
A20 binding inhibitor of NF-kappaB activation-2, ABIN-2, is a newly identified intracellular protein that interacts with the zinc finger protein A20. ABIN-2 inhibits nuclear factor-kappaB (NF-kappaB) activity and is a possible effector of A20 regulation of NF-kappaB. Although A20 is a potent inhibitor of endothelial apoptosis, the effect of ABIN-2 on apoptosis is not known. ABIN-2 also interacts with the endothelial receptor Tie2. This receptor is essential for blood vessel formation and promotes endothelial survival. Here we examine the effects of ABIN-2 on endothelial cell apoptosis and its potential involvement in Tie2-mediated endothelial survival. ABIN-2 was found to inhibit endothelial apoptosis and rescue cells from death following growth factor deprivation. The inhibitors of phosphatidylinositol-3 kinase, wortmannin and LY294002, suppressed ABIN-2 inhibition of endothelial cell death. Deletion of the carboxy-terminus of ABIN-2 removed its ability to inhibit apoptosis. Expression of truncated ABIN-2 prevented the Tie2-activating ligand angiopoietin-1 from inhibiting endothelial cell death.
No takes yet. Share an insight, caveat, or question.
Tadros et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: